Masimo has announced that Flagler Hospital has upgraded system-wide to Masimo SET pulse oximetry, the standard-of-care at leading hospitals around the world.
Flagler Hospital joins a growing and distinguished roster of health organizations using Masimo SET pulse oximetry, clinically shown to virtually eliminate false alarms and help clinicians detect life-threatening events.
The performance of Masimo SET pulse oximetry is proven by more than 100 independent and objective studies and thousands of clinical evaluations. Compared to other pulse oximeters, during patient motion and low perfusion, Masimo SET provides measurements when other pulse oximeters cannot, dramatically reduces false alarms (specificity), and accurately detects true alarms (sensitivity) that can indicate a deteriorating patient.
Most important, Masimo SET pulse oximetry has been shown to improve patient outcomes by helping clinicians reduce retinopathy of prematurity in neonates, screen newborns for critical congenital heart disease reduce ventilator weaning time and arterial blood gas measurements in the ICU, and save lives and costs while reducing rapid response activations and intensive care unit transfers on the general floor.
Masimo founder and CEO Joe Kiani noted the company is honored to partner with Flagler Hospital, which has a well-deserved reputation for having patient empathy and providing quality care.
"We also appreciate and share Flagler Hospital’s commitment to excellence and look forward to helping this great hospital and staff meet and exceed their patient-care needs," Kiani added.